A detailed history of Brinker Capital Investments, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 83,548 shares of NVO stock, worth $8.78 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
83,548
Previous 87,543 4.56%
Holding current value
$8.78 Million
Previous $8.72 Million 29.63%
% of portfolio
0.23%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$102.55 - $135.33 $409,687 - $540,643
-3,995 Reduced 4.56%
83,548 $11.3 Million
Q3 2022

Nov 01, 2022

BUY
$95.28 - $116.93 $360,348 - $442,229
3,782 Added 4.52%
87,543 $8.72 Million
Q2 2022

Jul 18, 2022

SELL
$103.24 - $121.81 $2.41 Million - $2.84 Million
-23,300 Reduced 21.76%
83,761 $9.33 Million
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $342,328 - $413,809
-3,677 Reduced 3.32%
107,061 $11.9 Million
Q4 2021

Feb 08, 2022

SELL
$95.88 - $117.08 $1.45 Million - $1.76 Million
-15,075 Reduced 11.98%
110,738 $12.4 Million
Q2 2021

Aug 03, 2021

BUY
$67.66 - $84.76 $1.85 Million - $2.32 Million
27,363 Added 27.79%
125,813 $10.5 Million
Q1 2021

May 12, 2021

SELL
$67.06 - $75.82 $1.33 Million - $1.5 Million
-19,775 Reduced 16.73%
98,450 $6.66 Million
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $2.74 Million - $3.16 Million
42,878 Added 56.91%
118,225 $8.26 Million
Q3 2020

Dec 03, 2020

BUY
$63.69 - $70.22 $4.8 Million - $5.29 Million
75,347 New
75,347 $5.23 Million
Q3 2019

Nov 14, 2019

SELL
$47.54 - $53.43 $280,010 - $314,702
-5,890 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $223,047 - $250,124
4,767 Added 424.49%
5,890 $301,000
Q1 2019

May 14, 2019

BUY
$46.36 - $52.63 $52,062 - $59,103
1,123 New
1,123 $59,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.